Loewenbaum Lilian S. → CollPlant Biotechnologies Ltd CLGN

On October 20, 2025, the Reporting Persons delivered a letter to the Board of Directors of the Issuer (the "Board") requesting the appointment of Nachum Shamir as Chairman in the immediate future and requesting consideration of adding other qualified individuals to the board. A copy of the letter is filed as Exhibit 3. On November 6, 2025, the Reporting Persons delivered a letter to the Board withdrawing their request for the appointment of Nachum Shamir as a director. A copy of the letter is filed as Exhibit 4. The acquisitions of Ordinary Shares by the Reporting Persons for investment purposes. The Reporting Persons intend to review their investment in the Issuer on a continuing basis and, depending upon the price of and other market conditions relating to the Ordinary Shares or other securities of the Issuer, subsequent developments affecting the Issuer, the Issuer's business and prospects, other investment and business opportunities available to the Reporting Persons, general stock market and economic conditions, tax considerations, and other factors deemed relevant, may form a plan or proposal to take any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D, in which case the Reporting Persons will file an amendment to this Schedule 13D. No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein.